Krensavage Asset Management »

Sanofi-Aventis SA shares owned by Krensavage Asset Management

Quarter-by-quarter ownership of Sanofi-Aventis SA (SNY) shares owned by Krensavage Asset Management from 13F filings

Historical chart of Krensavage Asset Management investment in Sanofi-Aventis SA

Tip: Access up to 7 years of quarterly data

All positions including Sanofi-Aventis SA held by Krensavage Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sanofi-Aventis SA by Krensavage Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.5M 150k 49.73

More positions owned by Krensavage Asset Management

Exelixis (EXEL)
United Therapeutics Corporation (UTHR)
Biogen Idec (BIIB)
Regeneron Pharmaceuticals (REGN)
Cardinal Health (CAH)
Taro Pharmaceutical Industries (TARO)
Alkermes (ALKS)
Jazz Pharmaceuticals (JAZZ)
Sanofi-Aventis SA (SNY)
Enanta Pharmaceuticals (ENTA)
Masimo Corporation (MASI)
Mural Oncology (MURA)

View all positions for Krensavage Asset Management

Top funds holding Sanofi-Aventis SA

Dodge & Cox
Fisher Investments
Robeco Investment Management
Bank of America Corporation
Bank of New York Mellon
Natixis Asset Management Advisors
Goldman Sachs Group
Raymond James & Associates
Hotchkis and Wiley Capital Management
Wells Fargo & Company
Royal Bank of Canada
Equity Investment Corp Acquisition
Brandes Investment Partners
Federated Investors
T. Rowe Price Associates

View all funds holding Sanofi-Aventis SA